ZFP14
gene geneOn this page
Also known as KIAA1559ZNF531
Summary
ZFP14 (ZFP14 zinc finger protein, HGNC:29312) is a protein-coding gene on chromosome 19q13.12, encoding Zinc finger protein 14 homolog (Q9HCL3). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to act upstream of or within blastocyst hatching. Predicted to be located in membrane. Predicted to be active in nucleus.
Source: NCBI Gene 57677 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 63 total
- MANE Select transcript:
NM_020917
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29312 |
| Approved symbol | ZFP14 |
| Name | ZFP14 zinc finger protein |
| Location | 19q13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KIAA1559, ZNF531 |
| Ensembl gene | ENSG00000142065 |
| Ensembl biotype | protein_coding |
| OMIM | 620163 |
| Entrez | 57677 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 protein_coding
ENST00000270001, ENST00000589280, ENST00000932313, ENST00000932314
RefSeq mRNA: 2 — MANE Select: NM_020917
NM_001297619, NM_020917
CCDS: CCDS33002
Canonical transcript exons
ENST00000270001 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000952043 | 36360435 | 36360533 |
| ENSE00001179324 | 36334453 | 36341590 |
| ENSE00001376614 | 36367884 | 36367971 |
| ENSE00002437943 | 36379163 | 36379201 |
| ENSE00002523547 | 36362112 | 36362238 |
Expression profiles
Bgee: expression breadth ubiquitous, 208 present calls, max score 85.77.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.1753 / max 159.4089, expressed in 1243 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 180670 | 4.1753 | 1243 |
Top tissues by expression
252 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 85.77 | gold quality |
| embryo | UBERON:0000922 | 80.56 | gold quality |
| ganglionic eminence | UBERON:0004023 | 80.56 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 78.74 | gold quality |
| calcaneal tendon | UBERON:0003701 | 78.64 | gold quality |
| ventricular zone | UBERON:0003053 | 78.05 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 76.77 | gold quality |
| corpus callosum | UBERON:0002336 | 73.78 | gold quality |
| right uterine tube | UBERON:0001302 | 73.38 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 73.24 | gold quality |
| adrenal tissue | UBERON:0018303 | 72.91 | gold quality |
| leukocyte | CL:0000738 | 72.66 | gold quality |
| prefrontal cortex | UBERON:0000451 | 72.53 | gold quality |
| monocyte | CL:0000576 | 72.52 | gold quality |
| islet of Langerhans | UBERON:0000006 | 72.36 | gold quality |
| cerebellar cortex | UBERON:0002129 | 72.29 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 72.21 | gold quality |
| spinal cord | UBERON:0002240 | 71.64 | gold quality |
| stromal cell of endometrium | CL:0002255 | 71.49 | gold quality |
| cerebellum | UBERON:0002037 | 71.48 | gold quality |
| primary visual cortex | UBERON:0002436 | 71.45 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 71.40 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 70.73 | gold quality |
| right coronary artery | UBERON:0001625 | 70.57 | gold quality |
| colonic epithelium | UBERON:0000397 | 70.56 | silver quality |
| smooth muscle tissue | UBERON:0001135 | 70.56 | gold quality |
| lymph node | UBERON:0000029 | 70.52 | gold quality |
| neocortex | UBERON:0001950 | 70.48 | gold quality |
| bone marrow cell | CL:0002092 | 70.43 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 70.25 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 5.93 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA1972.1 | ZFP14 | Factors with multiple dispersed zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:28092692
miRNA regulators (miRDB)
185 targeting ZFP14, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-4425 | 100.00 | 67.59 | 1049 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-4789-5P | 99.98 | 70.76 | 2721 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-LET-7F-2-3P | 99.98 | 70.98 | 2588 |
| HSA-MIR-1185-1-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-1185-2-3P | 99.98 | 71.04 | 2593 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp14 | ENSMUSG00000053985 |
| rattus_norvegicus | Zfp14 | ENSRNOG00000030932 |
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631), ZNF3 (ENSG00000166526)
Protein
Protein identifiers
Zinc finger protein 14 homolog — Q9HCL3 (reviewed: Q9HCL3)
Alternative names: Zinc finger protein 531
All UniProt accessions (2): Q9HCL3, K7EM99
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (2): NP_001284548, NP_065968* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050758 | Znf_C2H2-type | Family |
Pfam: PF00096, PF01352, PF13912
UniProt features (15 total): zinc finger region 13, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9HCL3-F1 | 71.16 | 0.02 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 117 (showing top):
GSE45365_NK_CELL_VS_CD11B_DC_UP, GCM_MAP4K4, GOBP_EMBRYO_DEVELOPMENT_ENDING_IN_BIRTH_OR_EGG_HATCHING, GCM_PTPRD, GCM_ZNF198, GOBP_IN_UTERO_EMBRYONIC_DEVELOPMENT, GOBP_BLASTOCYST_DEVELOPMENT, GCM_SUFU, GOBP_EMBRYO_DEVELOPMENT, BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP, GCM_MAP1B, GCM_PTK2, BOYLAN_MULTIPLE_MYELOMA_PCA3_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GCM_RAN
GO Biological Process (3): blastocyst hatching (GO:0001835), regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872), sequence-specific double-stranded DNA binding (GO:1990837)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| blastocyst development | 1 |
| hatching | 1 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
724 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZFP14 | CCDC24 | Q8N4L8 | 409 |
| ZFP14 | THNSL1 | Q8IYQ7 | 401 |
| ZFP14 | OR4C11 | Q6IEV9 | 399 |
| ZFP14 | TMEM217 | Q8N7C4 | 395 |
| ZFP14 | OR4A5 | Q8NH83 | 392 |
| ZFP14 | TMEM217B | A0A494BZU4 | 386 |
| ZFP14 | RSPH14 | Q9UHP6 | 385 |
| ZFP14 | HAUS5 | O94927 | 383 |
| ZFP14 | ANKRD7 | Q92527 | 382 |
| ZFP14 | OR4P4 | Q8NGL7 | 375 |
| ZFP14 | OR4C12 | Q96R67 | 367 |
| ZFP14 | OR4S2 | Q8NH73 | 358 |
| ZFP14 | OR2T11 | Q8NH01 | 357 |
| ZFP14 | CDK2AP2 | O75956 | 355 |
| ZFP14 | SMIM14 | Q96QK8 | 349 |
IntAct
11 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MAGOHB | ZFP14 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZFP14 | MAGT1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| NEK4 | E2F8 | psi-mi:“MI:0914”(association) | 0.350 |
| ZFP14 | IPO8 | psi-mi:“MI:0914”(association) | 0.350 |
| CDK11A | PRPF40A | psi-mi:“MI:0914”(association) | 0.350 |
| HK1 | ANXA2P2 | psi-mi:“MI:2364”(proximity) | 0.270 |
| EPHA2 | ARHGAP32 | psi-mi:“MI:2364”(proximity) | 0.270 |
| MERTK | NDUFA4 | psi-mi:“MI:2364”(proximity) | 0.270 |
| MAGOHB | ZFP14 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (8): ZFP14 (Proximity Label-MS), ZFP14 (Two-hybrid), ZFP14 (Proximity Label-MS), ZFP14 (Affinity Capture-MS), ZFP14 (Affinity Capture-MS), ZFP14 (Proximity Label-MS), ZFP14 (Proximity Label-MS), ZFP14 (Affinity Capture-MS)
ESM2 similar proteins: A2RRD8, A6NHJ4, B4DX44, O75346, P10077, P10755, P15621, P16372, P16373, P51786, P52737, P85977, Q0VGE8, Q14588, Q147U1, Q15928, Q15973, Q2M3X9, Q3KNS6, Q3MIS6, Q494X3, Q5HY98, Q5RBQ3, Q5REK1, Q5VIY5, Q60585, Q61751, Q6GQR8, Q7L2R6, Q7TSH9, Q8IYX0, Q8N782, Q8N823, Q8N988, Q8N9F8, Q8NA42, Q8NCK3, Q8NDP4, Q8NEP9, Q8TC21
Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
63 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 53 |
| Likely benign | 0 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
854 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:36367878:ACTT:A | donor_loss | 1.0000 |
| 19:36367879:CTTA:C | donor_loss | 1.0000 |
| 19:36367880:TTA:T | donor_loss | 1.0000 |
| 19:36367881:TA:T | donor_loss | 1.0000 |
| 19:36367882:A:AC | donor_gain | 1.0000 |
| 19:36367882:ACA:A | donor_loss | 1.0000 |
| 19:36367883:C:CC | donor_gain | 1.0000 |
| 19:36367883:CA:C | donor_gain | 1.0000 |
| 19:36367883:CATGG:C | donor_gain | 1.0000 |
| 19:36367967:CAGAG:C | acceptor_gain | 1.0000 |
| 19:36367969:GAG:G | acceptor_gain | 1.0000 |
| 19:36367970:AG:A | acceptor_gain | 1.0000 |
| 19:36367971:GCTGA:G | acceptor_loss | 1.0000 |
| 19:36367972:C:CC | acceptor_gain | 1.0000 |
| 19:36367972:CTGAA:C | acceptor_loss | 1.0000 |
| 19:36379159:TCA:T | donor_loss | 1.0000 |
| 19:36379160:CAC:C | donor_loss | 1.0000 |
| 19:36360459:C:A | donor_gain | 0.9900 |
| 19:36362106:CCTTA:C | donor_loss | 0.9900 |
| 19:36362107:CTTAC:C | donor_loss | 0.9900 |
| 19:36362108:TTA:T | donor_loss | 0.9900 |
| 19:36362109:TA:T | donor_loss | 0.9900 |
| 19:36362110:A:C | donor_loss | 0.9900 |
| 19:36362111:C:CA | donor_loss | 0.9900 |
| 19:36362151:C:A | donor_gain | 0.9900 |
| 19:36362237:CC:C | acceptor_gain | 0.9900 |
| 19:36362238:CC:C | acceptor_gain | 0.9900 |
| 19:36362238:CCTGA:C | acceptor_loss | 0.9900 |
| 19:36362239:C:CG | acceptor_loss | 0.9900 |
| 19:36367877:AACTT:A | donor_loss | 0.9900 |
AlphaMissense
3560 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:36341115:A:C | F237L | 0.996 |
| 19:36341115:A:T | F237L | 0.996 |
| 19:36341117:A:G | F237L | 0.996 |
| 19:36341199:A:C | F209L | 0.996 |
| 19:36341199:A:T | F209L | 0.996 |
| 19:36341201:A:G | F209L | 0.996 |
| 19:36341031:A:C | F265L | 0.995 |
| 19:36341031:A:T | F265L | 0.995 |
| 19:36341033:A:G | F265L | 0.995 |
| 19:36340527:A:C | F433L | 0.992 |
| 19:36340527:A:T | F433L | 0.992 |
| 19:36340529:A:G | F433L | 0.992 |
| 19:36340779:A:C | F349L | 0.992 |
| 19:36340779:A:T | F349L | 0.992 |
| 19:36340781:A:G | F349L | 0.992 |
| 19:36340359:A:C | F489L | 0.991 |
| 19:36340359:A:T | F489L | 0.991 |
| 19:36340361:A:G | F489L | 0.991 |
| 19:36340443:A:C | F461L | 0.991 |
| 19:36340443:A:T | F461L | 0.991 |
| 19:36340445:A:G | F461L | 0.991 |
| 19:36340947:A:C | F293L | 0.991 |
| 19:36340947:A:T | F293L | 0.991 |
| 19:36340949:A:G | F293L | 0.991 |
| 19:36340275:A:C | F517L | 0.990 |
| 19:36340275:A:T | F517L | 0.990 |
| 19:36340277:A:G | F517L | 0.990 |
| 19:36340611:A:C | F405L | 0.990 |
| 19:36340611:A:T | F405L | 0.990 |
| 19:36340613:A:G | F405L | 0.990 |
dbSNP variants (sampled 300 via entrez): RS1000003085 (19:36357783 C>T), RS1000111521 (19:36334229 G>A), RS1000119981 (19:36375675 A>G), RS1000227997 (19:36334003 A>T), RS1000285303 (19:36363484 C>A,G,T), RS1000316620 (19:36380940 AGT>A), RS1000422334 (19:36363198 T>C), RS1000538281 (19:36379385 A>C), RS1000543558 (19:36345761 C>G), RS1000608563 (19:36356553 C>G,T), RS1000729282 (19:36338804 C>T), RS1000782316 (19:36346171 G>C), RS1000809330 (19:36380571 C>T), RS1000812057 (19:36356261 T>C), RS1000900335 (19:36346463 CT>C,CTT,CTTT)
Disease associations
OMIM: gene MIM:620163 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004250_19 | Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL) | 2.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007965 | response to combination chemotherapy |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
34 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression, affects expression | 7 |
| Air Pollutants | affects expression, increases abundance, decreases expression | 4 |
| trichostatin A | affects cotreatment, decreases expression | 3 |
| entinostat | decreases expression, affects cotreatment | 2 |
| Panobinostat | affects cotreatment, decreases expression | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| bisphenol F | increases methylation | 1 |
| TAK-243 | increases sumoylation | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases methylation | 1 |
| 2-methyl-4-isothiazolin-3-one | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| aflatoxin B2 | affects methylation | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| abrine | decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Coal | increases abundance, decreases expression | 1 |
| Estradiol | decreases expression | 1 |
| Methotrexate | increases expression | 1 |
| Nickel | decreases expression | 1 |
| Ozone | increases abundance, affects expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Smoke | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.